These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 23781066)

  • 21. Enteropathogenic Escherichia coli effector EspF interacts with host protein Abcf2.
    Nougayrède JP; Foster GH; Donnenberg MS
    Cell Microbiol; 2007 Mar; 9(3):680-93. PubMed ID: 17064289
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Attaching and effacing Escherichia coli downregulate DNA mismatch repair protein in vitro and are associated with colorectal adenocarcinomas in humans.
    Maddocks OD; Short AJ; Donnenberg MS; Bader S; Harrison DJ
    PLoS One; 2009; 4(5):e5517. PubMed ID: 19436735
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Control of Type III Secretion System Effector/Chaperone Ratio Fosters Pathogen Adaptation to Host-Adherent Lifestyle.
    Elbaz N; Socol Y; Katsowich N; Rosenshine I
    mBio; 2019 Sep; 10(5):. PubMed ID: 31530678
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enterohaemorrhagic and enteropathogenic Escherichia coli Tir proteins trigger a common Nck-independent actin assembly pathway.
    Brady MJ; Campellone KG; Ghildiyal M; Leong JM
    Cell Microbiol; 2007 Sep; 9(9):2242-53. PubMed ID: 17521329
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative analysis of EspF variants in inhibition of Escherichia coli phagocytosis by macrophages and inhibition of E. coli translocation through human- and bovine-derived M cells.
    Tahoun A; Siszler G; Spears K; McAteer S; Tree J; Paxton E; Gillespie TL; Martinez-Argudo I; Jepson MA; Shaw DJ; Koegl M; Haas J; Gally DL; Mahajan A
    Infect Immun; 2011 Nov; 79(11):4716-29. PubMed ID: 21875965
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Map, but not EspF, induces breast epithelial cell apoptosis through ERK/DRP-1 pathway.
    Li Y; Zhu Y; Chu B; Liu N; Chen S; Wang J
    Vet Microbiol; 2022 Mar; 266():109367. PubMed ID: 35183820
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enteropathogenic and enterohaemorrhagic Escherichia coli: even more subversive elements.
    Wong AR; Pearson JS; Bright MD; Munera D; Robinson KS; Lee SF; Frankel G; Hartland EL
    Mol Microbiol; 2011 Jun; 80(6):1420-38. PubMed ID: 21488979
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The NleE/OspZ family of effector proteins is required for polymorphonuclear transepithelial migration, a characteristic shared by enteropathogenic Escherichia coli and Shigella flexneri infections.
    Zurawski DV; Mumy KL; Badea L; Prentice JA; Hartland EL; McCormick BA; Maurelli AT
    Infect Immun; 2008 Jan; 76(1):369-79. PubMed ID: 17984206
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional Characterization of EscK (Orf4), a Sorting Platform Component of the Enteropathogenic Escherichia coli Injectisome.
    Soto E; Espinosa N; Díaz-Guerrero M; Gaytán MO; Puente JL; González-Pedrajo B
    J Bacteriol; 2017 Jan; 199(1):. PubMed ID: 27795324
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enteropathogenic Escherichia coli EspF is targeted to mitochondria and is required to initiate the mitochondrial death pathway.
    Nougayrède JP; Donnenberg MS
    Cell Microbiol; 2004 Nov; 6(11):1097-111. PubMed ID: 15469437
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The enteropathogenic Escherichia coli (EPEC) Map effector is imported into the mitochondrial matrix by the TOM/Hsp70 system and alters organelle morphology.
    Papatheodorou P; Domańska G; Oxle M; Mathieu J; Selchow O; Kenny B; Rassow J
    Cell Microbiol; 2006 Apr; 8(4):677-89. PubMed ID: 16548893
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The bacterial virulence factor NleA is required for the disruption of intestinal tight junctions by enteropathogenic Escherichia coli.
    Thanabalasuriar A; Koutsouris A; Weflen A; Mimee M; Hecht G; Gruenheid S
    Cell Microbiol; 2010 Jan; 12(1):31-41. PubMed ID: 19712078
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Host cell attachment elicits posttranscriptional regulation in infecting enteropathogenic bacteria.
    Katsowich N; Elbaz N; Pal RR; Mills E; Kobi S; Kahan T; Rosenshine I
    Science; 2017 Feb; 355(6326):735-739. PubMed ID: 28209897
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enterohemorrhagic
    Fang Y; Fu M; Li X; Zhang B; Wan C
    Infect Immun; 2024 Apr; 92(4):e0000124. PubMed ID: 38415639
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The secreted effector protein EspZ is essential for virulence of rabbit enteropathogenic Escherichia coli.
    Wilbur JS; Byrd W; Ramamurthy S; Ledvina HE; Khirfan K; Riggs MW; Boedeker EC; Vedantam G; Viswanathan VK
    Infect Immun; 2015 Mar; 83(3):1139-49. PubMed ID: 25561713
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enteropathogenic Escherichia coli inhibits ileal sodium-dependent bile acid transporter ASBT.
    Annaba F; Sarwar Z; Gill RK; Ghosh A; Saksena S; Borthakur A; Hecht GA; Dudeja PK; Alrefai WA
    Am J Physiol Gastrointest Liver Physiol; 2012 May; 302(10):G1216-22. PubMed ID: 22403793
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nck adaptors, besides promoting N-WASP mediated actin-nucleation activity at pedestals, influence the cellular levels of enteropathogenic Escherichia coli Tir effector.
    Nieto-Pelegrin E; Kenny B; Martinez-Quiles N
    Cell Adh Migr; 2014; 8(4):404-17. PubMed ID: 25482634
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Complete Genome of the Atypical Enteropathogenic Escherichia coli Archetype Isolate E110019 Highlights a Role for Plasmids in Dissemination of the Type III Secreted Effector EspT.
    Hazen TH; Rasko DA
    Infect Immun; 2019 Oct; 87(10):. PubMed ID: 31358567
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The enteropathogenic E. coli (EPEC) Tir effector inhibits NF-κB activity by targeting TNFα receptor-associated factors.
    Ruchaud-Sparagano MH; Mühlen S; Dean P; Kenny B
    PLoS Pathog; 2011 Dec; 7(12):e1002414. PubMed ID: 22144899
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitative proteomic analysis of type III secretome of enteropathogenic Escherichia coli reveals an expanded effector repertoire for attaching/effacing bacterial pathogens.
    Deng W; Yu HB; de Hoog CL; Stoynov N; Li Y; Foster LJ; Finlay BB
    Mol Cell Proteomics; 2012 Sep; 11(9):692-709. PubMed ID: 22661456
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.